ArticleBMJ open2026

Regional citrate anticoagulation combined with nafamostat mesylate for continuous kidney replacement therapy in septic acute kidney injury patients: protocol for a prospective, three-arm, randomised controlled study (RCNM-CKRT).

Qing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.